Skip to Content

PROCEPT BioRobotics Corp PRCT

Morningstar Rating
$52.28 −0.20 (0.38%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PRCT is trading at a 14% discount.
Price
$53.90
Fair Value
$39.95
Uncertainty
Very High
1-Star Price
$428.24
5-Star Price
$45.83
Economic Moat
Jxyny
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PRCT is a good fit for your portfolio.

Trading Information

Previous Close Price
$52.48
Day Range
$50.6353.00
52-Week Range
$24.8354.79
Bid/Ask
$52.25 / $58.00
Market Cap
$2.69 Bil
Volume/Avg
498,153 / 498,245

Key Statistics

Price/Earnings (Normalized)
Price/Sales
18.21
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
626

Comparables

Valuation

Metric
PRCT
688277
ZIMV
Price/Earnings (Normalized)
9.69
Price/Book Value
9.492.851.05
Price/Sales
18.2118.500.91
Price/Cash Flow
12.29
Price/Earnings
PRCT
688277
ZIMV

Financial Strength

Metric
PRCT
688277
ZIMV
Quick Ratio
6.654.580.84
Current Ratio
7.635.492.78
Interest Coverage
−27.40−26.73−1.51
Quick Ratio
PRCT
688277
ZIMV

Profitability

Metric
PRCT
688277
ZIMV
Return on Assets (Normalized)
−25.31%−10.22%14.12%
Return on Equity (Normalized)
−38.72%−12.67%31.63%
Return on Invested Capital (Normalized)
−29.67%−10.97%18.79%
Return on Assets
PRCT
688277
ZIMV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesBqfnzyccPkdsz$185.5 Bil
SYK
Stryker CorpQxjvshkmRqbyq$128.2 Bil
MDT
Medtronic PLCPcvhgnrpPkpyls$106.7 Bil
BSX
Boston Scientific CorpHdymlyvqYvxnv$99.0 Bil
DXCM
DexCom IncGvczjpgrrRcyh$53.1 Bil
EW
Edwards Lifesciences CorpDgvcmprnvMgjjmx$52.8 Bil
ZBH
Zimmer Biomet Holdings IncCqdzjkgwmBxr$24.9 Bil
ALGN
Align Technology IncTvvmdtnbgGbtwwl$23.5 Bil
PHG
Koninklijke Philips NV ADRSgdkvvvlRcdnngw$18.9 Bil
PODD
Insulet CorpLpscbdkbpmZrykl$11.7 Bil

Sponsor Center